UW Undiagnosed Genetic Diseases Program

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 16, 2021

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
Rare DiseasesGenetic DiseaseUndiagnosed Disease
Interventions
DIAGNOSTIC_TEST

Trio Whole Genome Sequencing and Participant-Specific Research

"The initial evaluation begins with short-read genome sequencing of DNA extracted from blood of affected individual(s) and participating family members (The most common approach will be trio whole genome sequencing, which involves the affected child + their parents).~Additional evaluation may include: functional assessments, animal modeling, reverse phenotyping (may require an interim visit), epigenetic profiling, or clinical database matching through selective sharing of coded patient data with external collaborators (e.g., via Matchmaker Exchange and Phenome Central), long read genome sequencing, de novo genome assembly, RNA sequencing, and novel bioinformatics analyses"

Trial Locations (1)

53705

RECRUITING

University of Wisconsin School of Medicine and Public Health, Madison

All Listed Sponsors
collaborator

University of Wisconsin Center for Human Genomics and Precision Medicine

UNKNOWN

lead

University of Wisconsin, Madison

OTHER